Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
Molecular Cancer
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-24
DOI
10.1186/s12943-023-01813-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
- (2023) Chiara Falcomatà et al. Cancer Discovery
- Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
- (2023) Hsuan‐Chen Liu et al. Advanced Science
- Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
- (2023) Chengcao Sun et al. Science Advances
- Spatiotemporal dissection of tumor microenvironment via in situ sensing and monitoring in tumor-on-a-chip
- (2023) Lang Zhou et al. BIOSENSORS & BIOELECTRONICS
- Tumour extracellular vesicles and particles induce liver metabolic dysfunction
- (2023) Gang Wang et al. NATURE
- Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
- (2023) Luis A. Rojas et al. NATURE
- Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
- (2023) Joseph Tintelnot et al. NATURE
- Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
- (2022) Kebria Hezaveh et al. IMMUNITY
- Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis
- (2022) Hongkun Cai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein
- (2022) Chi Hin Wong et al. Molecular Cancer
- Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
- (2022) Luman Liu et al. Theranostics
- Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1+ fibroblast and CCR8+ Treg cell interactions
- (2022) Ming Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment
- (2022) Carolina J. Garcia Garcia et al. GASTROENTEROLOGY
- HIF-2 in Cancer-Associated Fibroblasts Polarizes Macrophages and Creates an Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
- (2022) Sundaram Ramakrishnan GASTROENTEROLOGY
- CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2
- (2022) Lingdong Meng et al. Molecular Cancer
- Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
- (2022) Yang Ge et al. Translational Oncology
- Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis
- (2022) Yue Sun et al. Journal of Immunology Research
- Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
- (2022) Xiaozhen Zhang et al. Journal for ImmunoTherapy of Cancer
- Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer
- (2022) Longyun Ye et al. EBioMedicine
- Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy
- (2022) Jiaqi Yang et al. EBioMedicine
- Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer
- (2022) Xiaowei Fu et al. Frontiers in Oncology
- LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
- (2022) Yanping Gao et al. Clinical and Translational Medicine
- Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy
- (2022) Kendelle J. Murphy et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
- (2022) Yang Chen et al. CANCER CELL
- Personalized tumor vaccine for pancreatic cancer
- (2022) Shira Orr et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis
- (2022) Zhiwei He et al. CANCER LETTERS
- Facts and Hopes in Immunotherapy of Pancreatic Cancer
- (2022) Bruno Bockorny et al. CLINICAL CANCER RESEARCH
- Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
- (2022) Zheng Gong et al. IMMUNITY
- Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot
- (2022) Nicholas A. Ullman et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors.
- (2022) Philippe L. Bedard et al. JOURNAL OF CLINICAL ONCOLOGY
- Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
- (2022) Dan He et al. MOLECULAR CELL
- FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling
- (2022) Zhongbo Zhang et al. MOLECULAR MEDICINE
- Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
- (2022) Lacey J. Padrón et al. NATURE MEDICINE
- BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer
- (2022) Brian Diskin et al. ONCOGENE
- Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)
- (2022) Sai Ping Lau et al. BMJ Open
- The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention
- (2022) Peter Gumberger et al. Cancers
- STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
- (2022) Julia E Lefler et al. Life Science Alliance
- Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial
- (2022) Dan Liu et al. BMC Medicine
- Tumor microbiome links cellular programs and immunity in pancreatic cancer
- (2022) Bassel Ghaddar et al. CANCER CELL
- Spatial transcriptomics
- (2022) Ana C. Anderson et al. CANCER CELL
- TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment
- (2022) Ya Han et al. NUCLEIC ACIDS RESEARCH
- Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert
- (2022) Xiaoqi Li et al. SEMINARS IN CANCER BIOLOGY
- LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2
- (2022) Jie Wang et al. Cell Death & Disease
- Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis
- (2022) Ashleigh R. Poh et al. Cell Reports
- GJB3 promotes pancreatic cancer liver metastasis by enhancing the polarization and survival of neutrophil
- (2022) Yanmiao Huo et al. Frontiers in Immunology
- Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer
- (2022) Xiaole Zhu et al. Frontiers in Genetics
- Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma
- (2022) Yingquan Ye et al. Frontiers in Genetics
- Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint
- (2022) Navin Kumar Verma et al. EBioMedicine
- The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
- (2022) Gauri Mirji et al. Science Immunology
- Metabolic reprogramming of immune cells in pancreatic cancer progression
- (2022) Hong Xiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Stromal reprogramming through dual PDGFRα/β blockade boosts the efficacy of anti-PD-1 immunotherapy in fibrotic tumors
- (2022) Takahiko Akiyama et al. CANCER RESEARCH
- Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche
- (2022) Vasileios Papalazarou et al. JOURNAL OF CELL SCIENCE
- Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
- (2022) Yu-Heng Zhu et al. CELLULAR ONCOLOGY
- TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer
- (2022) Maria Perez-Penco et al. Journal for ImmunoTherapy of Cancer
- Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors
- (2022) Tomoharu Yamada et al. Molecular Therapy-Oncolytics
- Host Cxcr2-dependent regulation of pancreatic cancer growth, angiogenesis, and metastasis
- (2021) Abhilasha Purohit et al. AMERICAN JOURNAL OF PATHOLOGY
- EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling
- (2021) Liqing Jia et al. BRITISH JOURNAL OF CANCER
- Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
- (2021) Huang Chen et al. ONCOGENE
- Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis
- (2021) Xu Wang et al. Nature Communications
- Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner
- (2021) Hongzhen Li et al. Clinical Epigenetics
- Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
- (2021) Yang Chen et al. CANCER CELL
- CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing
- (2021) Peng Shen et al. Molecular Cancer
- Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
- (2021) Davide Melisi et al. Journal for ImmunoTherapy of Cancer
- PIK3CB is associated with metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer
- (2021) Jianhua Qu et al. Journal of Advanced Research
- Trials and tribulations of pancreatic cancer immunotherapy
- (2021) Daniel R. Principe et al. CANCER LETTERS
- Treatment landscape of metastatic pancreatic cancer
- (2021) Sara De Dosso et al. CANCER TREATMENT REVIEWS
- Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression
- (2021) Zhengze Lu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment
- (2021) Zhibo Xie et al. GUT
- Long non-coding RNA: An immune cells perspective
- (2021) Salman Khan et al. LIFE SCIENCES
- Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells
- (2021) Alice Clare Newman et al. MOLECULAR CELL
- Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis
- (2021) Bin Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages
- (2021) Jiao Wu et al. Aging-US
- An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
- (2021) Bing Qi et al. Aging-US
- Modeling pancreatic cancer in mice for experimental therapeutics
- (2021) Kavita Mallya et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
- (2021) Xiaodong Hao et al. BIOMEDICINE & PHARMACOTHERAPY
- Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming
- (2021) Samantha M. Morrissey et al. Cell Metabolism
- CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
- (2021) Timothy N. J. Bullock Cellular & Molecular Immunology
- Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
- (2021) Katelyn T. Byrne et al. CLINICAL CANCER RESEARCH
- Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
- (2021) Xiaofei Zhu et al. LANCET ONCOLOGY
- Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis
- (2021) Yifan Cai et al. LIFE SCIENCES
- Targeting the IGF-axis potentiates immunotherapy for pancreatic ductal adenocarcinoma liver metastases by altering the immunosuppressive microenvironment.
- (2021) Masakazu Hashimoto et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
- (2021) Edoardo Del Poggetto et al. SCIENCE
- Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy
- (2021) Maria Mortoglou et al. Translational Oncology
- LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling
- (2021) Xudong Huang et al. Nature Communications
- A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
- (2021) Zheling Chen et al. Frontiers in Immunology
- Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
- (2021) Rita T. Lawlor et al. Cancers
- Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs
- (2021) Yiwei Li et al. Cancers
- Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
- (2021) Qiyao Zhang et al. Frontiers in Cell and Developmental Biology
- Pre-metastatic Niche Formation in Different Organs Induced by Tumor Extracellular Vesicles
- (2021) Qi Dong et al. Frontiers in Cell and Developmental Biology
- Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer
- (2021) Samantha B. Kemp et al. Cellular and Molecular Gastroenterology and Hepatology
- LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway
- (2021) Fengyu Xu et al. CANCER RESEARCH
- Macrophage-Targeting by CSF1/1R Blockade in Pancreatic Cancers
- (2021) Won Jin Ho et al. CANCER RESEARCH
- Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism
- (2021) Honglin Jiang et al. GASTROENTEROLOGY
- CD40 Agonists Alter the Pancreatic Cancer Microenvironment by Shifting the Macrophage Phenotype toward M1 and Suppress Human Pancreatic Cancer in Organotypic Slice Cultures
- (2021) Chae Yoon Lim et al. Gut and Liver
- Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma
- (2021) Qing Xia et al. ONCOGENE
- Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
- (2021) Ganji Purnachandra Nagaraju et al. SEMINARS IN CANCER BIOLOGY
- Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation
- (2021) Yong Gao et al. Bioengineered
- Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects
- (2021) Meggy Suarez-Carmona et al. Journal for ImmunoTherapy of Cancer
- DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
- (2021) Allison A Fitzgerald et al. Journal for ImmunoTherapy of Cancer
- Advances in Pancreatic Ductal Adenocarcinoma Treatment
- (2021) Eric M. Anderson et al. Cancers
- Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication
- (2021) Mareike Waldenmaier et al. Cancers
- Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
- (2020) Wenhao Luo et al. Cancer Cell International
- Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis
- (2020) Kosuke Ogawa et al. CANCER LETTERS
- Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma
- (2020) Min-Wei Yang et al. CANCER RESEARCH
- Metabolism of pancreatic cancer: paving the way to better anticancer strategies
- (2020) Cheng Qin et al. Molecular Cancer
- SINGLE-CELL IMMUNE COMPETENCY SIGNATURES ASSOCIATE WITH SURVIVAL IN PHASE 2 GVAX AND CRS-207 RANDOMIZED STUDIES IN METASTATIC PANCREATIC CANCER PATIENTS
- (2020) Nitya Nair et al. Cancer Immunology Research
- Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
- (2020) Ashleigh R. Poh et al. Cancer Immunology Research
- NK Cell-Based Immune Checkpoint Inhibition
- (2020) Muhammad Khan et al. Frontiers in Immunology
- Interferon gamma inhibits CXCL8–CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer
- (2020) Mingjie Zhang et al. Journal for ImmunoTherapy of Cancer
- Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
- (2020) Hanne Lind et al. Journal for ImmunoTherapy of Cancer
- Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
- (2020) Ya Luo et al. Frontiers in Oncology
- Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-mesothelin (CRS-207) With or Without Nivolumab in Patients with Pancreatic Cancer
- (2020) Takahiro Tsujikawa et al. CLINICAL CANCER RESEARCH
- Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer
- (2020) Jing Wang et al. MOLECULAR MEDICINE
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
- (2020) Keisuke Yamamoto et al. NATURE
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity
- (2020) Alexander H. Morrison et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task
- (2020) Guoying Ni et al. Human Vaccines & Immunotherapeutics
- Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
- (2020) Clara S. Mundry et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A Phase 2 Study of Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
- (2020) Annie A. Wu et al. CLINICAL CANCER RESEARCH
- Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
- (2020) Fuming Li et al. DEVELOPMENTAL CELL
- Targeting focal adhesion kinase in cancer cells and the tumor microenvironment
- (2020) James M. Murphy et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process
- (2020) Giovanni Barillari INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
- (2020) Cefan Zhou et al. Molecular Cancer
- Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
- (2020) Luis Felipe Campesato et al. Nature Communications
- CD200 promotes immunosuppression in the pancreatic tumor microenvironment
- (2020) Fouad Choueiry et al. Journal for ImmunoTherapy of Cancer
- CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity
- (2020) Austin P. Huffman et al. JCI Insight
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
- (2020) Wei Wang et al. CANCER CELL
- Challenges and Opportunities for Pancreatic Cancer Immunotherapy
- (2020) Adham S. Bear et al. CANCER CELL
- CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
- (2020) Andrew Cannon et al. CLINICAL CANCER RESEARCH
- PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
- (2020) Milad Ashrafizadeh et al. LIFE SCIENCES
- Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
- (2020) TingTing Tang et al. PHARMACOLOGY & THERAPEUTICS
- Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
- (2020) Rana Mhaidly et al. SEMINARS IN IMMUNOLOGY
- Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions
- (2020) Wei Lin et al. Genome Medicine
- Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer
- (2020) Xuguang Yang et al. Cancer Immunology Research
- Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
- (2020) Albiruni RA Razak et al. Journal for ImmunoTherapy of Cancer
- Mechanisms of T-Cell Exhaustion in Pancreatic Cancer
- (2020) Didem Saka et al. Cancers
- Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
- (2020) Ruiyuan Xu et al. Frontiers in Oncology
- Non-coding RNAs and potential therapeutic targeting in cancer
- (2020) Shusuke Toden et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
- (2020) Mark H O'Hara et al. LANCET ONCOLOGY
- Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells
- (2020) Chongyang Shen et al. CANCER LETTERS
- IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1
- (2019) Emma Eriksson et al. JOURNAL OF IMMUNOLOGY
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- Hepatocytes direct the formation of a pro-metastatic niche in the liver
- (2019) Jae W. Lee et al. NATURE
- A randomized phase II study of cabiralizumab (cabira) + nivolumab (nivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC).
- (2019) Andrea Wang-Gillam et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitochondria-centric bioenergetic characteristics in cancer stem-like cells
- (2019) Min-Kyue Shin et al. ARCHIVES OF PHARMACAL RESEARCH
- MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).
- (2019) Philippe Alexandre Cassier et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase Ib dose-escalation and cohort-expansion study of safety and activity of the transforming growth factor (TGF) β receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer.
- (2019) Davide Melisi et al. JOURNAL OF CLINICAL ONCOLOGY
- The microbiota and microbiome in pancreatic cancer: more influential than expected
- (2019) Miao-Yan Wei et al. Molecular Cancer
- The Hippo Signaling Pathway in Pancreatic Cancer
- (2019) DANIEL ANSARI et al. ANTICANCER RESEARCH
- Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway
- (2019) Zi Yin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The eighth edition of the American Joint Committee on Cancer (AJCC) distant metastases (M) stage classification for metastatic pancreatic neuroendocrine tumors might be feasible for metastatic pancreatic ductal adenocarcinomas
- (2019) JunMiao Wen et al. NEUROENDOCRINOLOGY
- The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
- (2019) Dannielle D. Engle et al. SCIENCE
- Immune checkpoints in the tumor microenvironment
- (2019) Salman M. Toor et al. SEMINARS IN CANCER BIOLOGY
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
- (2019) Erick Riquelme et al. CELL
- Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
- (2019) Anquan Shang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Current concepts of non-coding RNA regulation of immune checkpoints in cancer
- (2019) Maria Anna Smolle et al. MOLECULAR ASPECTS OF MEDICINE
- Next-generation computational tools for interrogating cancer immunity
- (2019) Francesca Finotello et al. NATURE REVIEWS GENETICS
- Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma
- (2019) Robert P. Jones et al. JAMA Surgery
- Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
- (2019) Rosalinda Trovato et al. Journal for ImmunoTherapy of Cancer
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis
- (2019) Jing Liang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924
- (2019) Shutao Pan et al. Cell Death & Disease
- Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
- (2019) Bradley N. Mills et al. Cell Reports
- Impact of Immunometabolism on Cancer Metastasis: A Focus on T Cells and Macrophages
- (2019) Nina C. Flerin et al. Cold Spring Harbor Perspectives in Medicine
- Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics
- (2019) Haseeb et al. Cells
- The therapeutic potential of targeting tryptophan catabolism in cancer
- (2019) Christiane A. Opitz et al. BRITISH JOURNAL OF CANCER
- CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
- (2019) Shi Yong Neo et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of the microbiome in occurrence, development and treatment of pancreatic cancer
- (2019) Yicheng Wang et al. Molecular Cancer
- The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies
- (2019) Sara K. Daniel et al. SEMINARS IN CANCER BIOLOGY
- 4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth
- (2019) Subhankar Panda et al. Scientific Reports
- The Immune Revolution: A Case for Priming, Not Checkpoint
- (2018) Robert H. Vonderheide CANCER CELL
- Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer
- (2018) Zhonghu Li et al. CANCER LETTERS
- Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer
- (2018) Valeria Quaranta et al. CANCER RESEARCH
- Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis
- (2018) Xiaofeng Wang et al. CANCER RESEARCH
- The role of hepatic macrophages in liver metastasis
- (2018) Jiri Keirsse et al. CELLULAR IMMUNOLOGY
- Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
- (2018) Julius Strauss et al. CLINICAL CANCER RESEARCH
- Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response
- (2018) Vrishketan Sethi et al. GASTROENTEROLOGY
- Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma
- (2018) Alex Y L Lee et al. GUT
- Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42
- (2018) Gina L. Razidlo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings
- (2018) Chi Fang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
- (2018) Demi S. Houg et al. Molecular Cancer
- Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
- (2018) Todd A Triplett et al. NATURE BIOTECHNOLOGY
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma
- (2018) Zhonghu Li et al. ONCOGENE
- Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
- (2018) Arnaud Pommier et al. SCIENCE
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway
- (2018) Yan Zhao et al. Oncotarget
- CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
- (2018) Santosh Kumar Singh et al. Scientific Reports
- CSF1R + Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
- (2018) Juliana B. Candido et al. Cell Reports
- Phase Ib/II study of lacnotuzumab (MCS110) combined with spartalizumab (PDR001) in patients (pts) with advanced tumors.
- (2018) Aitana Calvo et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
- (2018) Wei Wang et al. CANCER CELL
- Combination treatment of advanced pancreatic cancer using novel vaccine and traditional therapies
- (2018) Hiroto Matsui et al. Expert Review of Anticancer Therapy
- TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell Mediated Regression of Pancreatic Cancer
- (2018) Daniel R Principe et al. MOLECULAR CANCER THERAPEUTICS
- Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes
- (2018) Roxanne L. Massoumi et al. PANCREAS
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Wnt/beta-catenin pathway: modulating anticancer immune response
- (2017) Sachin Gopalkrishna Pai et al. Journal of Hematology & Oncology
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway
- (2017) Ke Chen et al. Molecular Oncology
- The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma
- (2017) Asma Begum et al. PLoS One
- Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis
- (2017) Hani Oweira et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1
- (2017) Guo Wu et al. Oncotarget
- Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation
- (2017) Zeqian Yu et al. Oncotarget
- FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
- (2017) Stefan N. Symeonides et al. Journal for ImmunoTherapy of Cancer
- The immune system in cancer metastasis: friend or foe?
- (2017) Louise M.E. Janssen et al. Journal for ImmunoTherapy of Cancer
- Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer
- (2016) Bingyan Liu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Characteristics and Significance of the Pre-metastatic Niche
- (2016) Yang Liu et al. CANCER CELL
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Colin W. Steele et al. CANCER CELL
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
- (2016) A. R. Chin et al. CLINICAL CANCER RESEARCH
- NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics
- (2016) Hin-Fung Tsang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Advances in understanding the molecular mechanism of pancreatic cancer metastasis
- (2016) Yong-Xing Du et al. Hepatobiliary & Pancreatic Diseases International
- Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy
- (2016) L. Li et al. MOLECULAR CANCER THERAPEUTICS
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
- (2016) Sebastian R. Nielsen et al. NATURE CELL BIOLOGY
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma
- (2016) X Wang et al. ONCOGENE
- Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53
- (2016) A K Swidnicka-Siergiejko et al. ONCOGENE
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Macrophage PI3K Drives Pancreatic Ductal Adenocarcinoma Progression
- (2016) M. M. Kaneda et al. Cancer Discovery
- Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
- (2016) V. Taucher et al. CELLULAR ONCOLOGY
- P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer
- (2016) Hiroaki Ono et al. Oncotarget
- MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3
- (2016) Chunyou Wang et al. Oncotarget
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway
- (2016) Lirong Zhang et al. PLoS One
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling
- (2015) I. Roy et al. CANCER RESEARCH
- Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
- (2015) Heng-Hsiung Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A niche role for cancer exosomes in metastasis
- (2015) Yun Zhang et al. NATURE CELL BIOLOGY
- Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
- (2015) Bruno Costa-Silva et al. NATURE CELL BIOLOGY
- IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
- (2015) Y. Pylayeva-Gupta et al. Cancer Discovery
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2
- (2015) D. G. Nowak et al. Cancer Discovery
- Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
- (2015) R. M. Perera et al. Cancer Discovery
- Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production
- (2015) Yingchao Fan et al. Oncotarget
- TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
- (2015) Kevin C. Soares et al. Oncotarget
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
- (2015) R. Winograd et al. Cancer Immunology Research
- Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling
- (2015) Hendrik Ungefroren et al. Oncotarget
- CXCL12-CXCR4 Promotes Proliferation and Invasion of Pancreatic Cancer Cells
- (2014) Bo Shen et al. Asian Pacific Journal of Cancer Prevention
- Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
- (2014) Yun-Peng Peng et al. BMC CANCER
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation
- (2014) Mako Nakaya et al. IMMUNITY
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
- (2014) Charlotte Giesen et al. NATURE METHODS
- CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis
- (2014) Ishan Roy et al. PLoS One
- eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation
- (2013) Chao Xu et al. CLINICAL & EXPERIMENTAL METASTASIS
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
- (2013) Jehan J. El-Jawhari et al. MOLECULAR IMMUNOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
- (2013) H Ouyang et al. ONCOGENE
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B7 family checkpoint regulators in immune regulation and disease
- (2013) Sabrina Ceeraz et al. TRENDS IN IMMUNOLOGY
- Molecular and Genetic Bases of Pancreatic Cancer
- (2012) Vanja Vaccaro et al. CURRENT DRUG TARGETS
- Combined Blockade of Integrin- 4 1 Plus Cytokines SDF-1 or IL-1 Potently Inhibits Tumor Inflammation and Growth
- (2011) M. C. Schmid et al. CANCER RESEARCH
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway
- (2008) Z Wang et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started